2seventy bio, Inc. (TSVT)

2seventy bio Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for 2seventy bio stock have an average target of 7.60, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 53.54% from the current stock price of 4.95.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$7.60	$5.00	$12
Change	+1.01%	+53.54%	+1.01%	+142.42%

Analyst Ratings

The average analyst rating for 2seventy bio stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	5	5	5	5	5	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Harrison Morgan Stanley	Morgan Stanley	Hold Maintains $6 → $5	Hold	Maintains	$6 → $5	+1.01%	Mar 14, 2025
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $9 → $5	Buy → Hold	Downgrades	$9 → $5	+1.01%	Mar 11, 2025
Matthew Harrison Morgan Stanley	Morgan Stanley	Hold Maintains $7 → $6	Hold	Maintains	$7 → $6	+21.21%	Jul 29, 2024
David Nierengarten Wedbush	Wedbush	Hold Reiterates $5	Hold	Reiterates	$5	+1.01%	Jun 27, 2024
John Newman Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $12 → $11	Strong Buy	Maintains	$12 → $11	+122.22%	May 9, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

65.41M

Increased by 72.76%

from 37.86M

Revenue Next Year

82.15M

Increased by 25.59%

from 65.41M

EPS This Year

-0.45

from -1.10

EPS Next Year

-0.24

from -0.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	248.12M	54.52M	91.50M	100.39M	37.86M	65.41M	82.15M	82.59M
Revenue Growth	460.15%	-78.03%	67.82%	9.72%	-62.28%	72.76%	25.59%	0.53%
EPS	-5.14	-12.44	-7.13	-4.42	-1.10	-0.45	-0.24	0.42
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	11.84
No. Analysts	-	-	-	-	-	7	6	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	94.4M	109.3M	85.0M
Avg	65.4M	82.2M	82.6M
Low	46.8M	59.1M	79.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	149.3%	67.1%	3.5%
Avg	72.8%	25.6%	0.5%
Low	23.6%	-9.7%	-3.4%

EPS Forecast

EPS	2025	2026	2028	2029
High	-0.22	0.17	0.43
Avg	-0.45	-0.24	0.42
Low	-0.86	-0.76	0.40

EPS Growth

EPS Growth	2025	2026	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.